RoyMTFirstMRMyreSACaciniW. Effect of co-trimoxazole and sulfamethoxazole on serum creatinine in normal subjects. Ther Drug Monitor (in press).
2.
BrautigamMFroesePBaethkeRKesselM. Zur Kreatininausscheidung beim Menschen nach Gabe von Co-trimoxazole. Klin Wochenschr1979; 57: 95–6.
3.
ShouvalDLigumskyMBen-IshayD. Effect of co-trimoxazole on normal creatinine clearance. Lancet1978; 1: 244–5.
4.
BerglundFKillanderJPompeiusR. Effect of trimethoprim-sulfamethoxazole on the renal excretion of creatinine in man. J Urol1975; 114: 803–8.
5.
HornBCottierP. Kreatininkonzentration im Serum vor und unter Behandlung mit Trimethoprim-Sulfamethoxazole (Bactrim). Schweiz Med Wochenschr1974; 104: 1809–12.
6.
BaileyRRLittlePJ. Deterioration in renal function in association with co-trimoxazole therapy. Med J Aust1976; 1: 914–6.
7.
BennettWMCravenR. Urinary tract infections in patients with severe renal disease — Treatment with ampicillin and trimethoprim-sulfamethoxazole. JAMA1976; 236: 946–8.
8.
KalowskiSNanraRSMathewTHKincaid-SmithP. Deterioration in renal function in association with co-trimoxazole therapy. Lancet1973; 1: 394–7.
9.
ScherwinJHolmP. Long-term treatment with sulphamethoxazole/trimethoprim (Bactrim) and nitrofurantoin in chronic urinary tract infections. Chemotherapy1977; 23: 282–8.